Cutera to Participate in Upcoming Investor Conferences
Get Alerts CUTR Hot Sheet
Join SI Premium – FREE
BRISBANE, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that Kevin Connors, the Company's President and Chief Executive Officer, will be presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 19th at 9:00a.m. EST in New York City.
An audio webcast of the presentation will be available live and can be accessed at the Investor Relations section of the Company's website, www.cutera.com.
Mr. Connors will also be attending the 27th Annual Piper Jaffray Healthcare Conference in New York City, where he will be participating on a panel, "Insights from Medtech Founder CEOs," to take place on Tuesday, December 1, 2015 at 12:00p.m. EST.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACT: Cutera, Inc. Ron Santilli Chief Financial Officer 415-657-5500 Investor Relations John Mills Integrated Corporate Relations, Inc. 646-277-1254 [email protected]Source: Cutera, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
- stayAPT Suites & Powerhouse Hotels Forge Partnership to Expand Presence with 30 New Locations
- TargusĀ® Advances its Sustainability Progress with New Product Innovations and Improved Reporting
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Piper Jaffray, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!